SCHEMBL28908346

SCHEMBL28908346

Nc1nccc2c1[nH]c(=O)n2C1CCCC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA3 P0DMS8 1/20 0.45
▸ ADORA2B P29275 1/20 0.45
▸ SIRT2 Q8IXJ6 1/20 0.43
▸ CHRM2 P08172 1/20 0.42
▸ CHRM4 P08173 1/20 0.42
▸ CHRM1 P11229 1/20 0.42
▸ CHRM3 P20309 1/20 0.42
▸ PGR P06401 3/20 0.40
▸ HCAR1 Q9BXC0 1/20 0.40
▸ JAK2 O60674 3/20 0.40
▸ JAK1 P23458 3/20 0.40
▸ JAK3 P52333 3/20 0.40
▸ OPRM1 P35372 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ RGS12 O14924 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ USP2 O75604 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25616564 0.88 CHRM2 (0.46) CHRM2CHRM4CHRM1CHRM3HCAR1
SCHEMBL30866992 0.87 RPS6KA5 (0.43) ADORA3ADORA2BSIRT2JAK2JAK1
SCHEMBL18818255 0.87 RPS6KA5 (0.43) ADORA3ADORA2BSIRT2JAK2JAK1
SCHEMBL18289975 0.87 RPS6KA5 (0.43) ADORA3ADORA2BSIRT2JAK2JAK1
SCHEMBL23216993 0.82 ALDH1A1 (0.40) ADORA3ADORA2BCHRM2CHRM4CHRM1
SCHEMBL18285551 0.82 BTK (0.45) JAK2JAK1JAK3
SCHEMBL18285554 0.82 BTK (0.45) JAK2JAK1JAK3
SCHEMBL30111811 0.82 BTK (0.39) JAK2JAK1JAK3OPRM1
SCHEMBL29737109 0.78 RXFP1 (0.34) OPRM1
SCHEMBL30111813 0.77 BTK (0.46) HCAR1JAK2JAK1PIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114380820-A Hetero-fused ring derivative and application thereof in medicine 海思科医药集团股份有限公司 2022-04-22 — — CN disclosed
Send feedback